Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2006-06-02

Original market date: See footnote 1

1992-12-31

Product name:

MENCEVAX AC PWS 50MCG/VIAL

DIN:

01962914 Electronic product monograph is not available

Company:

GLAXOSMITHKLINE INC
800 100 Milverton Drive
Mississauga
Ontario
Canada L5R 4H1

Class:

Human

Dosage form(s):

Powder For Solution

Route(s) of administration:

Subcutaneous

Number of active ingredient(s):

3

Schedule(s):

Schedule D

 

American Hospital Formulary Service (AHFS): See footnote 3

80:12.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

J07AH03 MENINGOCOCCUS, A, C, BIVALENT PURIFIED POLYSACC. ANTIGEN

Active ingredient group (AIG) number:See footnote5

0323419001

List of active ingredient(s)
Active ingredient(s) Strength
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A 50 MCG / VIAL
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C 50 MCG / VIAL
SODIUM CHLORIDE .5 ML / VIAL
Version 4.0.2
Date modified: